Email this article 
Post a Comment B-type natriuretic peptide in diagnosis of chronic heart failure in copd patients
- Authors: Tertichnaya S.P.1, Parshukova V.N.1
-
Affiliations:
- FGUZ "Clinical Hospital No. 83 FMBA of Russia"
- Issue: Vol 2, No 4 (2011)
- Pages: 29-34
- Section: Original Study Articles
- URL: https://journals.rcsi.science/clinpractice/article/view/83625
- DOI: https://doi.org/10.17816/clinpract83625
- ID: 83625
Cite item
Full Text
Abstract
The influence of chronic heart failure (CHF) on the В-type natriuretic peptide (BNP) level and BNP role in differential diagnosis of dyspnea in COPD and CHF was estimated.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Svetlana P. Tertichnaya
FGUZ "Clinical Hospital No. 83 FMBA of Russia"
Email: svetlanasmiles@yandex.ru
cardiologist of the highest category, department of cardiology, candidate of medical sciences
Russian Federation, MoscowVera N. Parshukova
FGUZ "Clinical Hospital No. 83 FMBA of Russia"
Author for correspondence.
Email: svetlanasmiles@yandex.ru
head Department of Cardiology, Candidate of Medical Sciences
Russian Federation, MoscowReferences
- Национальные клинические рекомендации ВНОК. Москва, 2008.
- Rutten F.H., Cramer M.J., Grobbee D.E. et al. Unrecognised heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Hear J.2005;26(18):1887-1894.
- Hogg J.C. Pathophysiology of airflou limitation in chronic obstructive pulmonary disease. Lancet. 2004;364(9435):709-721.
- Sin DD, Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular disease? The protential role of systematic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107( 11): 1514-1519.
- Ridker P.M., Buring J.E., Cook N.R., Rifai N. Creactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation. 2003;107(3):391-397.
- Ross R. Atherosclerosis, an inflammatory disease. N Engl J Med.l993;340(2):l 15-126.
- Danesh J, Wincup P, Walker M et al. Low grade inflammation and coronary heart disease: Prospective study and updated metaanalyses. BMJ. 2000; 321 (7255): 199-204.
- Ridker P.M., Rifai N., Pfeffer M.A. et al. Long-tem effects of pravastatin on plasma concentration of Creactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 1999; 100(3):230-235.
- Remes J., Miettinen H., Reunanen A., Pyorala К. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991; 12(3):315-321.
- Rao B.S., Cohn K.E., Eldridge F.L., Hancock E.W. Left ventricular failure secondary to chronic pulmonary desise. Am J Circulation.Med.l968;45(2)-229-241.
- Hunts S.A., Baker D.W., Chain M.N. et al. ACC/AHHA guidelines for the evaluation and management of chronic heart failure in the adult ;executive summary. A report of the American College of Cardiology/ American heart Association Task Force of Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of the Heart Failure). J Am Col Cardiol. 2001; 38(7):2101-2113.
- Rennard S. Clinical approach to patients with chronic obstructive pulmonary desise and cardiovascular disease. Proc Am Thorac Soc. 2005;2(l):94-100.
- Gehlbach В.К., Geppert E. The pulmonary manifestation of he left heart failure. Chest. 2004; 125(2):669-682.
- Wheeldon N.M., MacDonald T.M., Flucker C.J. et al. Echocardiography in chronic heart failure in the community. QJ Med.l993;86(l);17-23.
- Boussuges A., Pinet C., Molenat F. et al. Left atrial and ventricular filling in chronic obstructive pulmonary desise. An Echocardiographic and Doppler study. Am J Respir Crit Care Med. 2000; 162(2Ptl):670-675.
- Pennel DJ, Sehtem UP, Haggins CB et al. Clinical indications for cardiovascular magnetic resonance (CMR):consensus panel report. J Cardiovasc Magn Reson.2004;6(4):727-765.
- Агеев Ф.Т., Овчинников А.Г. Мозговой натрийуретический гормон и дисфункция левого желудочка. Сердечная недостаточность. 2009; 5. №5 (55):271.
- Redifield М.М., Rodeheffer R.J., Jacobsen S.J. et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension. 1996; 28(6):998-994.
- Nishicumi T., Matsuoka H. Routine measurement of natriuretic peptide to quide the diagnosis and management of chronic heart failure. Circulation.2006; 109(25):e 25-236.
Supplementary files
